Reply to Can quantified pathologic response assessed as residual tumor burden be a promising staging system for patients with rectal cancer treated with chemoradiation followed by surgery?

Dipen M. Maru; Atin A. Agarwal; Chung Yuan Hu; George J. Chang

doi:10.1002/cncr.28559

Reply to Can quantified pathologic response assessed as residual tumor burden be a promising staging system for patients with rectal cancer treated with chemoradiation followed by surgery?

Dipen M. Maru, Atin A. Agarwal, Chung Yuan Hu, George J. Chang

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	1282
Number of pages	1
Journal	Cancer
Volume	120
Issue number	8
DOIs	https://doi.org/10.1002/cncr.28559
State	Published - Apr 15 2014

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1002/cncr.28559

Cite this

@article{be6ddbd8c6f445abb8d816d196668bbc,

title = "Reply to Can quantified pathologic response assessed as residual tumor burden be a promising staging system for patients with rectal cancer treated with chemoradiation followed by surgery?",

author = "Maru, {Dipen M.} and Agarwal, {Atin A.} and Hu, {Chung Yuan} and Chang, {George J.}",

year = "2014",

month = apr,

day = "15",

doi = "10.1002/cncr.28559",

language = "English (US)",

volume = "120",

pages = "1282",

journal = "Cancer",

issn = "0008-543X",